Treatment of older patients with chronic lymphocytic leukemia Journal Article


Author: Lamanna, N.
Article Title: Treatment of older patients with chronic lymphocytic leukemia
Abstract: Chronic lymphocytic leukemia (CLL) is typically a disease of older individuals. Yet most of the literature on various chemotherapeutic regimens includes patients who are 10 to 15 years younger than the median age at diagnosis of this disease. The older patient population is grossly underrepresented in clinical trials. Currently available therapies are often too toxic for this older patient population, so their efficacy is reduced. This review discusses some of the results of treatment in older patients with CLL. A discussion of factors that often affect outcome, such as comorbidities, renal function, bone marrow reserve, and infection, are also reviewed, along with quality of life.
Keywords: treatment outcome; aged; aged, 80 and over; fludarabine; lenalidomide; review; cancer combination chemotherapy; antineoplastic agents; clinical trials as topic; treatment; rituximab; antineoplastic agent; quality of life; infection; bone marrow; cyclophosphamide; kidney failure; age factors; age; kidney function; comorbidity; chronic lymphatic leukemia; elderly care; leukemia, lymphocytic, chronic, b-cell; clinical trials; alemtuzumab; chlorambucil; pentostatin; cll; creatinine clearance; gm-csf; chronic lymphocytic leukemia; older patients; clinical trial (topic); renal insufficiency; infections; tumor lysis; myelosuppression; chemoimmunotherapy; hypogammaglobulinemia
Journal Title: Current Hematologic Malignancy Reports
Volume: 7
Issue: 1
ISSN: 1558-8211
Publisher: Springer  
Date Published: 2012-03-01
Start Page: 21
End Page: 25
Language: English
DOI: 10.1007/s11899-011-0111-0
PUBMED: 22234621
PROVIDER: scopus
DOI/URL:
Notes: --- - "Export Date: 1 May 2012" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Nicole Lamanna
    60 Lamanna